ADVERTISEMENT
Scientists first tested their ideas in mice, with encouraging results: castalagin helped the animals’ immune systems fight can.cer more effectively.
Inspired by these findings, the team is now moving forward with human clinical trials.
The next phase will involve 45 patients with lung can.cer or melanoma, who will take castalagin in capsule form to see how it influences their treatment outcomes.
If these trials go well, they could pave the way for a revolutionary new approach to can.cer therapy.
A Small Fruit with Enormous Potential
ADVERTISEMENT
ADVERTISEMENT
